Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.

<h4>Objective</h4>The vaginal microbiota in bacterial vaginosis (BV) typically has low abundance of lactic acid producing lactobacilli. Lactic acid has properties that may make it effective for treating BV and/or restoring an optimal lactobacillus-dominated vaginal microbiota. We conduct...

Full description

Bibliographic Details
Main Authors: Erica L Plummer, Catriona S Bradshaw, Michelle Doyle, Christopher K Fairley, Gerald L Murray, Deborah Bateson, Lindi Masson, Josephine Slifirski, Gilda Tachedjian, Lenka A Vodstrcil
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0246953
_version_ 1818717021324443648
author Erica L Plummer
Catriona S Bradshaw
Michelle Doyle
Christopher K Fairley
Gerald L Murray
Deborah Bateson
Lindi Masson
Josephine Slifirski
Gilda Tachedjian
Lenka A Vodstrcil
author_facet Erica L Plummer
Catriona S Bradshaw
Michelle Doyle
Christopher K Fairley
Gerald L Murray
Deborah Bateson
Lindi Masson
Josephine Slifirski
Gilda Tachedjian
Lenka A Vodstrcil
author_sort Erica L Plummer
collection DOAJ
description <h4>Objective</h4>The vaginal microbiota in bacterial vaginosis (BV) typically has low abundance of lactic acid producing lactobacilli. Lactic acid has properties that may make it effective for treating BV and/or restoring an optimal lactobacillus-dominated vaginal microbiota. We conducted a systematic review to describe the effect of intravaginal lactic acid-containing products on BV cure, and their impact on vaginal microbiota composition (PROSPERO registration: CRD42018115982).<h4>Methods</h4>PubMed, Embase and OVID were searched from inception to November 2019 to identify eligible studies. Included studies evaluated an intravaginal lactic acid-containing product and reported BV cure using established diagnostic methods, and/or vaginal microbiota composition using molecular methods. Studies were independently screened and assessed, and the proportion of women cured post-treatment was calculated. Study results were described in a qualitative manner.<h4>Results</h4>We identified 1,883 articles and assessed 57 full-texts for eligibility. Seven different lactic acid-containing products were evaluated and differed with respect to excipients, lactic acid concentration and pH. Most studies had medium or high risk of bias. Three trials compared the efficacy of a lactic acid-containing product to metronidazole for BV cure. One study found lactic acid to be equivalent to metronidazole and two studies found lactic acid to be significantly inferior to metronidazole. Two studies included a control group receiving a placebo or no treatment. One reported lactic acid to be superior than no treatment and the other reported lactic acid to be equivalent to placebo. Lactic acid-containing products did not significantly impact the vaginal microbiota composition.<h4>Conclusion</h4>There is a lack of high-quality evidence to support the use of lactic acid-containing products for BV cure or vaginal microbiota modulation. However, adequately powered and rigorous randomised trials with accompanying vaginal microbiota data are needed to evaluate the efficacy of lactic acid as a BV treatment strategy.
first_indexed 2024-12-17T19:28:32Z
format Article
id doaj.art-e063320998394841852db8a3c347b6cf
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-17T19:28:32Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e063320998394841852db8a3c347b6cf2022-12-21T21:35:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01162e024695310.1371/journal.pone.0246953Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.Erica L PlummerCatriona S BradshawMichelle DoyleChristopher K FairleyGerald L MurrayDeborah BatesonLindi MassonJosephine SlifirskiGilda TachedjianLenka A Vodstrcil<h4>Objective</h4>The vaginal microbiota in bacterial vaginosis (BV) typically has low abundance of lactic acid producing lactobacilli. Lactic acid has properties that may make it effective for treating BV and/or restoring an optimal lactobacillus-dominated vaginal microbiota. We conducted a systematic review to describe the effect of intravaginal lactic acid-containing products on BV cure, and their impact on vaginal microbiota composition (PROSPERO registration: CRD42018115982).<h4>Methods</h4>PubMed, Embase and OVID were searched from inception to November 2019 to identify eligible studies. Included studies evaluated an intravaginal lactic acid-containing product and reported BV cure using established diagnostic methods, and/or vaginal microbiota composition using molecular methods. Studies were independently screened and assessed, and the proportion of women cured post-treatment was calculated. Study results were described in a qualitative manner.<h4>Results</h4>We identified 1,883 articles and assessed 57 full-texts for eligibility. Seven different lactic acid-containing products were evaluated and differed with respect to excipients, lactic acid concentration and pH. Most studies had medium or high risk of bias. Three trials compared the efficacy of a lactic acid-containing product to metronidazole for BV cure. One study found lactic acid to be equivalent to metronidazole and two studies found lactic acid to be significantly inferior to metronidazole. Two studies included a control group receiving a placebo or no treatment. One reported lactic acid to be superior than no treatment and the other reported lactic acid to be equivalent to placebo. Lactic acid-containing products did not significantly impact the vaginal microbiota composition.<h4>Conclusion</h4>There is a lack of high-quality evidence to support the use of lactic acid-containing products for BV cure or vaginal microbiota modulation. However, adequately powered and rigorous randomised trials with accompanying vaginal microbiota data are needed to evaluate the efficacy of lactic acid as a BV treatment strategy.https://doi.org/10.1371/journal.pone.0246953
spellingShingle Erica L Plummer
Catriona S Bradshaw
Michelle Doyle
Christopher K Fairley
Gerald L Murray
Deborah Bateson
Lindi Masson
Josephine Slifirski
Gilda Tachedjian
Lenka A Vodstrcil
Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.
PLoS ONE
title Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.
title_full Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.
title_fullStr Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.
title_full_unstemmed Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.
title_short Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.
title_sort lactic acid containing products for bacterial vaginosis and their impact on the vaginal microbiota a systematic review
url https://doi.org/10.1371/journal.pone.0246953
work_keys_str_mv AT ericalplummer lacticacidcontainingproductsforbacterialvaginosisandtheirimpactonthevaginalmicrobiotaasystematicreview
AT catrionasbradshaw lacticacidcontainingproductsforbacterialvaginosisandtheirimpactonthevaginalmicrobiotaasystematicreview
AT michelledoyle lacticacidcontainingproductsforbacterialvaginosisandtheirimpactonthevaginalmicrobiotaasystematicreview
AT christopherkfairley lacticacidcontainingproductsforbacterialvaginosisandtheirimpactonthevaginalmicrobiotaasystematicreview
AT geraldlmurray lacticacidcontainingproductsforbacterialvaginosisandtheirimpactonthevaginalmicrobiotaasystematicreview
AT deborahbateson lacticacidcontainingproductsforbacterialvaginosisandtheirimpactonthevaginalmicrobiotaasystematicreview
AT lindimasson lacticacidcontainingproductsforbacterialvaginosisandtheirimpactonthevaginalmicrobiotaasystematicreview
AT josephineslifirski lacticacidcontainingproductsforbacterialvaginosisandtheirimpactonthevaginalmicrobiotaasystematicreview
AT gildatachedjian lacticacidcontainingproductsforbacterialvaginosisandtheirimpactonthevaginalmicrobiotaasystematicreview
AT lenkaavodstrcil lacticacidcontainingproductsforbacterialvaginosisandtheirimpactonthevaginalmicrobiotaasystematicreview